Published by Josh White on 13th March 2024
(Sharecast News) - Cell engineering technology specialist MaxCyte reported total fourth quarter revenue of $15.7m on Wednesday, up 26% on the same period in 2022.
URL: http://www.digitallook.com/dl/news/story/34152416/...